NSEOutcome of Board Meeting4d ago · 5 Nov 2026, 08:34 pm
Outcome of Board Meeting
Vaishali Pharma Limited · VAISHALI
✦ AI SummaryMgmt Change
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026, where the Board considered and approved the appointment of two new independent directors, Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah, and decided to defer the proposal for issuance of equity shares by way of preferential issue for further evaluation and consideration.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026.
Attachments (1)
📄pdf
Download →
VAISHALI_05112026203413_OutcomeVPL.pdf
View document text
Date: 05th November, 2026
National Stock Exchange of India Ltd.,
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex,
Bandra (E), Mumbai – 400 051.
Stock Code: VAISHALI
Sub: Outcome of Board Meeting held on Thursday, 05th November, 2026
Dear Sir/Madam,
In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations &
Disclosure Requirements) Regulations, 2015 ("the Listing Regulations"), we wish to inform you
that, in their meeting held today i.e. 05th November, 2026 has inter-alia considered and
approved the following:
1. Appointment of Mr. Rohil Sanjay Desai (DIN: 12030412) as an Additional Director of the
Company under Independent Category with effect from Thursday, 05th November, 2026,
subject to approval of Members;
Accordingly, the details required under Regulation 30 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 is attached herewith
as “Annexure I”.
2. Appointment of Mr. Ketur Kishor Shah (DIN: 11956456) as an Additional Director of the
Company under Independent Category with effect from Thursday, 05th November, 2026,
subject to approval of Members;
Accordingly, the details required under Regulation 30 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 is attached herewith
as “Annexure I”.
3. The Board, inter alia, considered the proposal for issuance of equity shares of the Company
by way of preferential issue in accordance with the applicable provisions of the Companies
Act, 2013, the SEBI Listing Regulations, the SEBI (Issue of Capital and Disclosure
Requirements) Regulations, 2018, and other applicable laws.
After due deliberations, the Board decided to defer the proposal for issuance of equity
shares by way of preferential issue for further evaluation and consideration. Accordingly,
no decision was taken by the Board in respect of the said proposal at the meeting.
The Company shall make the necessary disclosures to the Stock Exchange(s) in accordance with
the applicable provisions of the SEBI Listing Regulations as and when the matter is considered
and approved by the Board.
The meeting of the Board commenced at 07:00 P.M. and concluded at 08:15 P.M.
Kindly take the above on record.
Thanking You,
Yours Faithfully,
For Vaishali Pharma Limited
Vishwa Mekhia
Company Secretary Cum Compliance Officer
Annexure-I
Details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular
No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026:
Sr. Particulars Details Details
1. Name & DIN Mr. Rohil Sanjay Desai Mr. Ketur Kishor Shah
(DIN: 12030412) (DIN: 11956456)
2. Reason for Change viz. Appointment of Mr. Rohil Appointment of Mr. Ketur
appointment, re- Sanjay Desai as an Kishor Shah as an Additional
appointment, resignation, Additional Director on the Director on the Board of the
removal, death or Board of the Company Company designated as a
otherwise designated as a Non- Non-Executive Independent
Executive Independent Director
Director
3. Date of appointment and November 5, 2026 November 5, 2026
term of appointment Term of Appointment Term of Appointment
The term of his appointment The term of his appointment
as an Independent Director as an Independent Director
shall be for a period of five shall be for a period of five
(5) years, not liable to retire (5) years, not liable to retire
by rotation, subject to the by rotation, subject to the
approval of shareholders, as approval of shareholders, as
per regulatory requirements. per regulatory requirements.
4. Brief Profile (in case of Mr. Rohil Desai is a chef, Mr. Ketur Shah is a finance
Appointment) hospitality entrepreneur, professional with
and food content creator qualifications in CA and
with a background in CFA, and over 15 years of
Pharmacy and formal experience in the financial
training in Culinary Arts services industry. Currently
from the Academy of Pastry serving as the Head –
and Culinary Arts, Mumbai. Investment Banking at Abans
He is the founder of APRIL Financial Services, Mr. Ketur
Studio / APRIL Hospitality, Shah brings extensive
an artisanal Italian-inspired expertise in investment
gelateria and café, where he banking, capital markets, and
leads culinary operations, corporate finance.
gelato production, menu
development, and brand
experiences. With experience
in culinary R&D, kitchen
management, food styling,
content creation, and private
catering, Rohil brings
together culinary creativity,
entrepreneurial vision, and a
passion for hospitality.
5. Disclosure of He is not related to any He is not related to any
relationships between Director of the Company Director of the Company and
directors (in case of and satisfies the criteria of satisfies the criteria of
appointment of a independence prescribed independence prescribed
Director) under the Companies Act, under the Companies Act,
2013, and SEBI Listing 2013, and SEBI Listing
Regulations. Regulations.
6. Information as required He is not debarred from He is not debarred from
pursuant to BSE Circular holding the office of Director holding the office of Director
with ref. No. by virtue of any SEBI order by virtue of any SEBI order
LIST/COMP/14/2018- or any other such authority. or any other such authority.
19 and the National Stock
Exchange of India with
ref. No.
NSE/CML/2018/24,
dated 20th June 2018